Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
3078636 | Neurologic Clinics | 2009 | 11 Pages |
Abstract
The substantial societal and individual burdens associated with tension-type headache (TTH) constitute a previously overlooked major public health issue. TTH is prevalent, affecting up to 78% of the general population, and 3% suffer from chronic TTH. Pericranial myofascial nociception probably is important for the pathophysiology of episodic TTH, whereas sensitization of central nociceptive pathways seems responsible for the conversion of episodic to chronic TTH. Headache-related disability usually can be reduced by identification of trigger factors combined with nonpharmacologic and pharmacologic treatments, but effective treatment modalities are lacking. Benefits can be gained by development of specific and effective treatment strategies.
Related Topics
Health Sciences
Medicine and Dentistry
Clinical Neurology
Authors
Lars MD, PhD, Rigmor MD, PhD,